


Ask a doctor about a prescription for Aziter
Azithromycin Dihydrate
Azyter contains azithromycin, a macrolide antibiotic.
Azyter is used to treat various bacterial eye infections in adults (including the elderly) and children from birth to 17 years.
Before starting to use Azyter, consult your doctor, the doctor treating your child, pharmacist, or nurse
In case other eye medications need to be used, the following should be done:
Page 1 5

first, administer another eye medication,

wait 15 minutes,

then administer Azyter as the last one.
Inform your doctor, the doctor treating your child, or pharmacist about all medications currently or recently used by the patient, as well as any planned medications.
Azyter can be used during pregnancy.
The treating doctor may prescribe Azyter to a pregnant woman if necessary.
There is limited data indicating that azithromycin passes into breast milk.
This medication can be used during breastfeeding.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before using this medication.
After administration, temporary blurred vision may occur. In such cases, wait until the symptoms resolve before driving or operating machinery.
Azyter should only be used for eye administration (eye drops).
This medication should always be used as directed by your doctor. In case of doubts, consult your doctor, the doctor treating your child, or pharmacist.
Dosage
The recommended dose for adults (including the elderly) and children from birth to 17 years is 1 drop twice a day to the affected eye: one drop in the morning and one drop in the evening.
Treatment duration is 3 days.
Administration method:
To properly administer Azyter, follow these steps:
DO NOT INJECT, DO NOT SWALLOW
Do not take a double dose to make up for a missed dose.
Page 2 5
Always consult your doctor if you decide to stop treatment.
In case of further doubts about using this medication, consult your doctor, pharmacist, or nurse.
Like all medications, Azyter can cause side effects, although not everybody gets them.
Uncommon: may affect up to 1 in 100 people:
Frequency not known: frequency cannot be estimated from the available data
The following side effects have been reported with the use of the medication:
Very common: may affect more than 1 in 10 people:
Common: may affect up to 1 in 10 people:
Uncommon: may affect up to 1 in 100 people:
Page 3 5
If you experience any side effects, including any side effects not listed in the leaflet, inform your doctor, the doctor treating your child, pharmacist, or nurse. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
phone: +48 22 49 21 301
fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Reporting side effects will help gather more information on the safety of the medication.
Keep the medication out of sight and reach of children.
Do not use this medication after the expiration date stated on the outer packaging and single-dose container. The expiration date is the last day of the specified month.
Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of unused medications. This will help protect the environment.
Azyter is an eye drop solution (eye drops, solution) in single-dose containers made of LDPE, containing 0.25 g of medication, in a sachet, in a cardboard box. Azyter is a clear, colorless to slightly yellowish, oily liquid.
The cardboard box contains 6 single-dose containers in a sachet, which is sufficient for a single treatment course.
For more detailed information, contact the marketing authorization holder or parallel importer.
Laboratoires THEA, 12, rue Louis Blériot, 63017 Clermont-Ferrand Cedex 2, France
Laboratoire UNITHER, 1 rue de l’Arquerie, 50200 Coutances, France
Page 4 5
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Authorization number in Greece, the country of export: 56059/25-08-2015
This medicinal product is authorized for sale in the Member States of the European Economic Area under the following names:
Austria, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland,
Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Sweden, United Kingdom ....................................................................................................................... – Azyter
Spain ..................................................................................................................... – AZYDROP
[Information about the trademark]
Page 5 5
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Aziter – subject to medical assessment and local rules.